Cell therapy for Parkinson's disease: problems and prospects
A Björklund - Stem Cells: Nuclear Reprogramming and …, 2005 - Wiley Online Library
Cell replacement therapy in Parkinson's disease (PD) has so far been based on the use of
primary dopaminergic (DA) neuroblasts obtained from the brain of aborted human fetuses …
primary dopaminergic (DA) neuroblasts obtained from the brain of aborted human fetuses …
Cell therapy for Parkinson's disease: problems and prospects.
A Björklund - Novartis Foundation Symposium, 2005 - portal.research.lu.se
Cell replacement therapy in Parkinson's disease (PD) has so far been based on the use of
primary dopaminergic (DA) neuroblasts obtained from the brain of aborted human fetuses …
primary dopaminergic (DA) neuroblasts obtained from the brain of aborted human fetuses …
Cell therapy for Parkinson's disease: problems and prospects
A Bjrklund - NUCLEAR REPROGRAMMING AND …, 2005 - Wiley Online Library
Cell replacement therapy in Parkinson's disease (PD) has so far been based on the use of
primary dopaminergic (DA) neuroblasts obtained from the brain of aborted human fetuses …
primary dopaminergic (DA) neuroblasts obtained from the brain of aborted human fetuses …
Cell therapy for Parkinson's disease: problems and prospects.
A Björklund - Novartis Foundation Symposium, 2005 - lup.lub.lu.se
Cell replacement therapy in Parkinson's disease (PD) has so far been based on the use of
primary dopaminergic (DA) neuroblasts obtained from the brain of aborted human fetuses …
primary dopaminergic (DA) neuroblasts obtained from the brain of aborted human fetuses …
Cell therapy for Parkinson's disease: problems and prospects.
A Björklund - Novartis Foundation Symposium, 2005 - europepmc.org
Cell replacement therapy in Parkinson's disease (PD) has so far been based on the use of
primary dopaminergic (DA) neuroblasts obtained from the brain of aborted human fetuses …
primary dopaminergic (DA) neuroblasts obtained from the brain of aborted human fetuses …
Cell therapy for Parkinson's disease: problems and prospects
A Björklund - Stem Cells: Nuclear Reprogramming and …, 2005 - books.google.com
Cell replacement therapy in Parkinson's disease (PD) has so far been based on the use of
primary dopaminergic (DA) neuroblasts obtained from the brain of aborted human fetuses …
primary dopaminergic (DA) neuroblasts obtained from the brain of aborted human fetuses …
[引用][C] Cell therapy for Parkinson's disease: problems and prospects
A BJORKLUND - Novartis Found Symp., 2005 - cir.nii.ac.jp
Cell therapy for Parkinson's disease : problems and prospects | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
Cell therapy for Parkinson's disease: problems and prospects
A Björklund - Novartis Foundation symposium, 2005 - pubmed.ncbi.nlm.nih.gov
Cell replacement therapy in Parkinson's disease (PD) has so far been based on the use of
primary dopaminergic (DA) neuroblasts obtained from the brain of aborted human fetuses …
primary dopaminergic (DA) neuroblasts obtained from the brain of aborted human fetuses …
Cell therapy for Parkinson's disease: problems and prospects
A Bjrklund - Stem Cells: Nuclear Reprogramming and …, 2005 - books.google.com
Cell replacement therapy in Parkinson's disease (PD) has so far been based on the use of
primary dopaminergic (DA) neuroblasts obtained from the brain of aborted human fetuses …
primary dopaminergic (DA) neuroblasts obtained from the brain of aborted human fetuses …